Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None., Horby P., Mafham M., Peto L., Campbell M., Pessoa-Amorim G., Spata E., Staplin N., Emberson J., Prudon B., Hine P., Brown T., Green C., Sarkar R., Desai P., Yates B., Bewick T., Tiberi S., Felton T., Baillie K., Buch M., Chappell L., Day J., Faust S., Jaki T., Jeffery K., Juszczak E., Lim WS., Montgomery A., Mumford A., Rowan K., Thwaites G., Weinreich D., Haynes R., Landray M.

DOI

10.1101/2021.06.15.21258542

Type

Preprint

Publication Date

16/06/2021

Keywords

RECOVERY Collaborative Group

Permalink Original publication